Efficacy of Oral C5aR Inhibitor CCX168 on Non-Renal Disease Activity in Patients withAntineutrophil Cytoplasmic Antibody-Associated Vasculitis
(2014) American Society of Nephrology — Location: Philadelphia (11.November.2014)
Files
JayneetalEfficacyoforalC5aRinhibitorCCX168onnon-renaldiseaseactivityinpatientswithantineutrophilcytoplasmicantibody-associatedvasculitisabstractASN2014.pdf
Closed Access - Adobe PDF
- 82.41 KB
Details
- Authors
- Affiliations
Citations
Jayne, D. R., Bruchfeld, A., Schaier, M., Jadoul, M., Segelmark, M., Selga, D., Szombati, I., Venning, M., Hugo, C., Potarca, A., Schall, T. J., & Bekker, P. (2014). Efficacy of Oral C5aR Inhibitor CCX168 on Non-Renal Disease Activity in Patients withAntineutrophil Cytoplasmic Antibody-Associated Vasculitis. American Society of Nephrology Renal Week 2014. Published. American Society of Nephrology, Philadelphia. https://hdl.handle.net/2078.5/230136